Jiangxi Yuneng Pharmaceutical Co., Ltd. was established in 2002 and is located in the National Economic and Technological Development Zone—Jinggangshan Economic and Technological Development Zone, covering an area of 113,390 square meters. The company specializes in the research, development, production, and sales of steroid hormone APIs and their intermediates. It currently employs 130 people, with 18.46% holding a bachelor's degree or higher and 38.46% holding an associate degree or higher.
        Guided by the philosophy of independent and university-collaborative new product development, the company focuses on the development and application of green production processes for steroid compounds and bio-fermentation technologies. The R&D department oversees two independent research institutes and two joint laboratories, enabling the entire process from small-scale trials to pilot-scale and large-scale production.
        The company's factory primarily produces corticosteroids, sex hormones, progestogens, and other APIs and intermediates, with production technologies reaching domestic or international leading levels.Products that have achieved large-scale production and regular supply include: Deflazacort, Hydrocortisone, Dexamethasone, Dexamethasone Sodium Phosphate, Budesonide, Estrone, Estradiol, Estriol, 17α-Hydroxyprogesterone, Medroxyprogesterone Acetate, among others. Among these, the annual production capacity for Deflazacort is 12 tons, and for Hydrocortisone, it is 15 tons. All products are manufactured in compliance with GMP requirements, and their quality meets international standards such as the US Pharmacopoeia and European Pharmacopoeia.
        Adhering to the principles of "equality, mutual benefit, and friendly cooperation," the company warmly welcomes domestic and international partners to join hands for mutual development.